Participant satisfaction in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study

被引:5
|
作者
Kusek, JW
Lee, JY
Charleston, J
Faulkner, M
Levell, B
Milligan, S
Norris, K
机构
[1] UNIV ALABAMA,DEPT MED,BIRMINGHAM,AL 35294
[2] UNIV ALABAMA,DEPT BIOSTAT,BIRMINGHAM,AL 35294
[3] JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT EPIDEMIOL,BALTIMORE,MD
[4] MEHARRY MED COLL,DEPT MED,NASHVILLE,TN 37208
[5] MOREHOUSE SCH MED,ATLANTA,GA 30310
[6] CASE WESTERN RESERVE UNIV,MANDEL SCH APPL SCI,CLEVELAND,OH 44106
[7] CHARLES R DREW UNIV MED & SCI,DEPT MED,LOS ANGELES,CA 90059
来源
CONTROLLED CLINICAL TRIALS | 1996年 / 17卷 / 04期
关键词
AASK Pilot Study; hypertension; kidney disease;
D O I
10.1016/S0197-2456(97)82682-7
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Seventy-one of the 94 eligible participants of the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study completed a self-administered questionnaire at the end of the study to determine their satisfaction with the study, difficulties encountered during participation, and willingness to join a similar study in the future. Nearly all of the participants (97%) believed that they would directly benefit from the study; treatment and information from physicians (94%), and more knowledge (92%) and closer monitoring (90%) of their physical condition were often cited as the ways in which the AASK Pilot Study helped. The two most commonly reported problems in the study were side effects from antihypertensive drugs (27%) and travel to and from the clinic (25%). Eighty-two percent of those who completed the survey indicated that they would volunteer for a similar study in the future. We conclude that AASK Pilot Study participants believed that they would benefit directly from the trial and that medical aspects of the trial were of major importance. Side effects from antihypertensive drugs and difficulties in travel to and from the clinic were commonly encountered problems and may hinder long-term participation in the AASK Full-Scale Trial.
引用
收藏
页码:S47 / S54
页数:8
相关论文
共 50 条
  • [11] Cardiovascular outcomes in the African American (AA) study of hypertension and kidney disease (AASK).
    Norris, K
    Bourgoignie, J
    Gassman, J
    Hebert, L
    Middleton, J
    Phillips, R
    Randall, O
    Rostand, S
    Sherer, S
    Toto, R
    Wright, J
    Wang, XL
    Kopple, J
    Lewis, J
    Greene, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 673A - 673A
  • [12] Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK)
    Gassman, JJ
    Greene, T
    Wright, JT
    Agodoa, L
    Bakris, G
    Beck, GJ
    Douglas, J
    Jamerson, K
    Lewis, J
    Kutner, M
    Randall, OS
    Wang, SR
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07): : S154 - S165
  • [13] Assessing medication adherence by pill count and electronic monitoring in the African American study of kidney disease and hypertension (AASK) pilot study
    Lee, JY
    Kusek, JW
    Greene, PG
    Bernhard, S
    Norris, K
    Smith, D
    Wilkening, B
    Wright, T
    AMERICAN JOURNAL OF HYPERTENSION, 1996, 9 (08) : 719 - 725
  • [14] Baseline predictors of renal disease progression in the African American (AA) study of hypertension and kidney disease (AASK)
    Norris, K
    Greene, T
    Kopple, J
    Lea, J
    Lipkowitz, M
    Miller, E
    Richardson, A
    Rostand, S
    Wang, XL
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 190A - 190A
  • [15] Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study
    Sika, Mohammed
    Lewis, Julia
    Douglas, Janice
    Erlinger, Thomas
    Dowie, Donna
    Lipkowitz, Michael
    Lash, James
    Cornish-Zirker, Denise
    Peterson, Gail
    Toto, Robert
    Kusek, John
    Appel, Lawrence
    Kendrick, Cynthia
    Gassman, Jennifer
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 50 (01) : 78 - 89
  • [16] Left ventricular geometric patterns in the African American study of kidney disease and hypertension (AASK) cohort
    de Backer, Tine L.
    Peterson, Gail
    Lansky, Alexandra J.
    Agodoa, Larry
    Appel, Larry
    Brittain, Karen
    Gassmann, Jennifer
    Kendrick, Cindy
    Lipkowitz, Michael
    Wright, Jackson T.
    Phillips, Robert A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 399A - 399A
  • [17] Effect of blood pressure control and antihypertensive drug regimen on quality of life: The African American Study of Kidney Disease and Hypertension (AASK) Pilot Study
    Kusek, JW
    Lee, JY
    Smith, DE
    Milligan, S
    Faulkner, M
    Cornell, CE
    Kopple, JD
    Greene, PG
    CONTROLLED CLINICAL TRIALS, 1996, 17 (04): : S40 - S46
  • [18] Adding ambulatory blood pressure monitoring (ABPM) to the African American study of kidney disease and hypertension (AASK)
    Gassman, J
    Charleston, J
    Gabriel, A
    Hiremath, L
    Brittain, K
    Phillips, R
    Appel, L
    CONTROLLED CLINICAL TRIALS, 2003, 24 : 175S - 175S
  • [19] ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: The African American Study of Kidney Disease and Hypertension (AASK) trial
    Douglas, JG
    Agodoa, L
    KIDNEY INTERNATIONAL, 2003, 63 : 74 - 76
  • [20] Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK)
    Chen, Teresa K.
    Estrella, Michelle M.
    Astor, Brad C.
    Greene, Tom
    Wang, Xuelei
    Grams, Morgan E.
    Appel, Lawrence J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (08) : 1329 - 1335